Navigation Links
Growing Preference for Composite Materials in Shoulder Fixation and Knee Ligament Reconstruction Markets
Date:1/13/2009

Composite segments of shoulder fixation and knee ligament reconstruction markets to grow at rates above 50% and 20%, respectively, from 2008 to 2013, according to Millennium Research Group

WALTHAM, Mass., Jan. 13 /PRNewswire/ -- According to Millennium Research Group's (MRG's) US Markets for Orthopedic Soft Tissue Solutions 2009 report, there is a growing preference for the use of composite materials in both shoulder fixation and knee ligament reconstruction. Each composite device market will see impressive compound annual growth rates from 2008 to 2013 of over 50% and over 20%, respectively.

Over the next five years, physicians will increasingly shift away from using polymer suture anchors to composite suture anchors in shoulder fixation. Suture anchors composed of composite materials are often embedded with various biocompatible and bioactive materials, such as hydroxyapatite and tricalcium phosphate. In 2008, many companies, including market leader Arthrex, launched composite suture anchors to compete with DePuy Mitek -- the only company to actively market a composite suture anchor in 2007. Over the next 5 years, several more composite suture anchor products are expected to enter the market.

"In the resorbable bone-patellar tendon-bone (BTB) fixation device segment, there is also a growing shift away from polymer-based materials towards composite devices -- in this case interference screws," says Kevin Flewwelling, Manager of MRG's Orthopedics division. "Composite materials not only resorb into the body, but promote bone growth too. In the coming years, new products, such as the BioComposite Interference Screw from Arthrex, will stimulate additional interest in the market as manufacturers promote the use of composite materials. This interest is expected to translate into more than 20% annual growth in the BTB composite interference screw segment of the knee ligament reconstruc
'/>"/>

SOURCE Millennium Research Group
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Growing Shortage of Gastroenterologists to Affect Screening Capacity for #2 Cancer Killer
2. Dr. Mitchell L. Petusevsky, M.D., F.C.C.P. Meets Growing Demand for the Treatment of Sleep and Pulmonary Disorders
3. Veteran Rehab Specialist, Ted ONeill, Joins Fast-Growing Alliance Seating & Mobility in Pennsylvania
4. Launch of New Independent Aging Company Will Address the Needs of the Growing Senior Population
5. Colorectal Cancer Racial Gap Still Growing
6. Leading U.S. Cancer Organizations Unite Against the Growing Global Cancer Burden
7. NHHF Scholarship Program Targets Growing Demand for Diversity Among Health Care Professionals
8. CPF Updates Patient Education Materials to Meet Growing Demand for Pulmonary Fibrosis Information
9. Americas 5000 Fastest-Growing Private Companies Revealed
10. Happiness Spreads Through African Villages Thanks to Growing Contributions from Long Term Care Insurance Professionals
11. NxStage(R) Ranked 14th Fastest Growing Company in North America on Deloittes 2008 Technology Fast 500
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... of C3: Colorectal Cancer Coalition,s advocacy efforts, $15 million ... included in the final Fiscal Year 2010 Defense Appropriations ... research cancers, like colorectal cancer, that are not addressed ... programs run by the U.S. Army Medical Research and ... funding for this new cancer research program was included ...
(Date:12/16/2009)... is long-term goal, researchers say , , WEDNESDAY, Dec. ... to predict whether a patient will suffer a second ... "This is an important new tool because studies have ... after a first stroke are more likely to die ... General Hospital and Harvard Medical School, said in an ...
(Date:12/16/2009)... plays a role in reducing inflammation in the lungs ... variant that plays a role in inflammation seems to ... as adults who smoke. , Researchers also found that ... had a lower risk of developing chronic obstructive pulmonary ... smoking. , "The gene seems to be protective of ...
(Date:12/16/2009)... health and environmental concerns about the emerging nanotechnology industry, ... behavior of nanoparticles in municipal sewage treatment plants ... published in ACS, journal Environmental Science & Technology ... Ecology and Hydrology and colleagues note that experts predict ... less than 1/1000th the width of a human hair ...
(Date:12/16/2009)... commonly found in fatty fish and algae help ... by the American Psychological Association. The finding connects ... people with schizophrenia; bipolar, obsessive-compulsive, and attention-deficit hyperactivity ... nervous system. , The study, reported in ... evidence that fish is brain food. The key ...
Breaking Medicine News(10 mins):Health News:House Creates New Cancer Research Program 2Health News:House Creates New Cancer Research Program 3Health News:New Stroke Tool May Predict Early Recurrence 2Health News:Gene Variant Seems to Guard Against Asthma, COPD 2Health News:Gene Variant Seems to Guard Against Asthma, COPD 3Health News:Behavior modification could ease concerns about nanoparticles 2Health News:New study links DHA type of omega-3 to better nervous-system function 2
... retinopathy who were destined to go blind within five ... treatment with Avastin , a well-known cancer drug, according ... Archives of Ophthalmology. ,This is a major breakthrough ... therapy and commonly develop radiation retinopathy, said Paul T. ...
... where the potentially lethal H5N1 strain of bird flu was ... ,"All the turkeys on the farm have been ... in the area, around 1,000 birds in all," Czech veterinary ... completed today (Friday)," he added. ,The H5N1 strain of ...
... people in Vietnam in the first six months of the ... period last year, the health ministry said Friday. ... 15 percent rise to 19,144 new infections from the mosquito-borne ... delta. ,Malaysia and other Southeast Asian countries have ...
... have formed a new compound AN2690, that might help ... an enzyme crucial for the protein synthesis of fungal ... team of researchers including Dickon Alley and Stephen Cusack ... Biology Laboratory (EMBL) outstation in Grenoble, France. ,AN2690 ...
... an Anglo-American company has been allowed to store white ... by the US Food and Drug Administration. ... immune system that defend the body against both infectious ... take 480-millilitre of blood from interested healthy individuals and ...
... environmental group Friday welcomed the European Union (EU) Parliament's resolution ... the Indian government to do likewise. ,Toxics ... Wednesday. ,The group had called upon governments across ... United Nations Environment Programme (UNEP) in February. ...
Other Medicine News:Health News:Untreatable Eye Disease Improves With Avastin 2Health News:Researchers Devise New Compound to Treat Fungal Infections 2
(Date:12/16/2009)... DATATRAK International, Inc. (OTCQX: DATA), a technology ... solutions for the clinical trials industry, today ... eClinical Software. This release advances the ... delivery and introduces two new mechanisms for ... Learning Center(TM) and the DATATRAK Learning Manager(TM). ...
(Date:12/16/2009)... Dec. 16 Hospira, Inc. (NYSE: ... delivery company, today announced that it will host a ... results and projections for 2010 on Thursday, Feb. 4, ... will release its fourth-quarter and full-year 2009 results earlier ... the conference call. ,, A live webcast of the ...
(Date:12/16/2009)... 16 EuroPharma, Inc. signs exclusive ... use of super absorbency BCM-95® curcumin and ... The exclusive distribution territory for these ... store channel and professional channel, which includes ... BCM-95® is a highly absorbable curcumin. ...
Breaking Medicine Technology:DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 2DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 3DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 4EuroPharma Exclusive Distributor of BCM-95 and BosPure 2EuroPharma Exclusive Distributor of BCM-95 and BosPure 3Researchers prolong the plasma half life of biopharmaceutical proteins 14192 1Researchers prolong the plasma half life of biopharmaceutical proteins 14192 2Boston Scientific PROMUS 28R 29 and First Generation TAXUS 28R 29 Express 28R 29 Stents Continue Excellent Performance in SPIRIT III Trial 57889 1Boston Scientific PROMUS 28R 29 and First Generation TAXUS 28R 29 Express 28R 29 Stents Continue Excellent Performance in SPIRIT III Trial 57889 2Boston Scientific PROMUS 28R 29 and First Generation TAXUS 28R 29 Express 28R 29 Stents Continue Excellent Performance in SPIRIT III Trial 57889 3Boston Scientific PROMUS 28R 29 and First Generation TAXUS 28R 29 Express 28R 29 Stents Continue Excellent Performance in SPIRIT III Trial 57889 4KATE AND CASSIE CARE 21 This Harvest Season Charity Reaps the Benefits of Kate 26 Cassie wines 57888 1KATE AND CASSIE CARE 21 This Harvest Season Charity Reaps the Benefits of Kate 26 Cassie wines 57888 2
... Phase 2 Colorectal and Prostate Trials -- Company to ... Experts - SOUTH SAN FRANCISCO, Calif., May 4 ... announced that the Company will present new data from ... Company,s lead product candidate, at poster sessions during the ...
... Submits sNDA for NEXIUM Capsules for Risk Reduction of ... 4 AstraZeneca (NYSE: AZN ) today ... to the U.S. Food and Drug Administration (FDA) seeking ... esomeprazole magnesium for the risk reduction of low dose ...
Other Medicine Technology:Poniard Pharmaceuticals to Present New Data from Phase 2 Clinical Trials of Picoplatin in Multiple Tumor Types at the 45th Annual Meeting of the American Society of Clinical Oncology 2Poniard Pharmaceuticals to Present New Data from Phase 2 Clinical Trials of Picoplatin in Multiple Tumor Types at the 45th Annual Meeting of the American Society of Clinical Oncology 3Poniard Pharmaceuticals to Present New Data from Phase 2 Clinical Trials of Picoplatin in Multiple Tumor Types at the 45th Annual Meeting of the American Society of Clinical Oncology 4AstraZeneca Submits NDA for Low Dose Aspirin/Esomeprazole Combination Product 2AstraZeneca Submits NDA for Low Dose Aspirin/Esomeprazole Combination Product 3AstraZeneca Submits NDA for Low Dose Aspirin/Esomeprazole Combination Product 4
... your data for future generations. Most gels can ... backing plate of our gel dryer, covering them ... over them to hold the cellophane flat. Tut's ... with an open area somewhat larger than the ...
... large sequencing gels or multiple smaller gels. Rugged design ... lasting durability and corrosion resistance., Large 40 x ... Drying Rate - large sequence gels can be dried ... of temperature and time , Cool-down ...
Inquire...
... and safely, the Hoefer GD 2000 uses a ... beneath the gel through a heavy aluminum platen. ... to 33 x 44 cm in as little ... even heat distribution and even vacuum distribution under ...
Medicine Products: